Robert C. Pordy,William J. Sasiela,Joyce B. Harp,Corinne Hanotin,Laurence Bessac
申请号：
US16022255
公开号：
US20180296672A1
申请日:
2018.06.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides methods for treating hypercholesterolemia. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P. The methods of the present invention are useful for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy.
